@BaronDestructo@robertgraham If the “broad appeal” reasoning was really it, that is absurd. One of the things you guys always did best, was keeping things understandable to someone who pops in on a random episode. Scripting in reminders of how things work in universe while not making it feel forced or dumb.
@BaronDestructo Whoever made the final decision to axe this, may you get cancer and die slowly and painfully. Fuck you.
To have gone this far, and done this much right, only to say “just kidding”, you deserve it.
An injectable small molecule targeting the same pathways as Retatrutide: GLP-1, GIP, and Glucagon with an ultra long half-life (up to one month, YTBD for certain) relative to current GLP-1s.
It uses an upgraded Albumin binder/linker relative to the current pharmaceutical industry standard that generally results in a half-life of 5-7 days.
Its binding affinity for GLP-1, GIP, and the Glucagon receptor is around >20x higher than that of Retatrutide, allowing for extremely small doses.
It is completely novel, so if Eli Lilly doesn’t like it, they can go to hell.
It will eventually become available in a pill form in all likelihood, and will be an absolute game changer, blowing both Orforglipron (oral) and Retatrutide (injectable) out of the water. This will crush obesity in the vast majority of people who have it, improve lifespan and nutrient partitioning, and drive Eli Lilly crazy (one of the best possible outcomes🙂).
Can I please classify as a normie? 😉
Aptera stock (SEV) future Valuation prediction:
$20.72 -> $82.87/share once they are at a run rate of 20,000 vehicles/year.
Market capitalization of:
$800M -> $3.2B
This could occur by Q3 2027 -> Q3 2028 (just my gut feel)
Assumptions:
◦20,000 vehicles sold/year
◦Average sale price = $40,000
◦Assign a P/S ratio (multiple) of 1-4x annual revenue = market cap
◦Current market cap = $91,130,000
◦Current stock price: $2.36
Market capitalization estimate:
20,000*40,000*1 = $800,000,000
20,000*40,000*4 = $3,200,000,000
Share price estimate:
($800,000,000/$91,130,000)*$2.36
= $20.72
($3,200,000,000/$91,130,000)*$2.36= $82.87
@aptera_motors stock ($SEV) future Valuation prediction:
$20.72 -> $82.87/share once they are at a run rate of 20,000 vehicles/year.
Market capitalization of:
$800M -> $3.2B
This could occur by Q3 2027 -> Q3 2028 (just my gut feel)
Assumptions:
◦20,000 vehicles sold/year
◦Average sale price = $40,000
◦Assign a P/S ratio (multiple) of 1-4x annual revenue = market cap
◦Current market cap = $91,130,000
◦Current stock price: $2.36
Market capitalization estimate:
20,000*40,000*1 = $800,000,000
20,000*40,000*4 = $3,200,000,000
Share price estimate:
($800,000,000/$91,130,000)*$2.36
= $20.72
($3,200,000,000/$91,130,000)*$2.36= $82.87
Aptera will be showcasing the first vehicle off our validation assembly line to the public this Saturday at San Diego Cars & Coffee’s 10-year anniversary. Come see it up close and celebrate this milestone with us.
Date: Saturday, March 7 | 9AM–11AM
Location: 8820 Kenamar Dr, San Diego, CA
Due to the expected volume of attendees, we will not be accommodating anyone sitting inside the vehicle.
A message to President Trump on behalf of the people of Iran fighting for freedom against the terrorist Islamic Dictatorship:
@realDonaldTrump@WhiteHouse
@_TomHoward If you look at the breakdown, you will notice all of the tests samples that flunked were the 6mg vials, the 12mg and 16mg quantities tested acceptably. Don’t order the 6mg quantity.
@MWilliams0135@cybertruck I’m pretty sure FSD works even if the tailgate is down, it just doesn’t use the rear camera for decisions making then I believe .